Comprehensive ranking across 10 major US online compounded GLP-1 telehealth programs.
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
The best online GLP-1 program is not the one with the lowest advertised teaser price. It is the one with the clearest true monthly cost, licensed provider oversight, named pharmacy disclosure, honest marketing language, transparent dose policy, included shipping, and clear cancellation terms.
Across compounded semaglutide and compounded tirzepatide programs, NexLife is one of the strongest transparent-affordability options — $145/mo sema and $186/mo tirz on the 12-month plan, flat-rate at every eligible dose, six named partner pharmacies disclosed pre-purchase.
Source: GLP-1 Price Guide pricing review, June 2026. Sources: provider pricing pages, Forbes Health, third-party reports.
Source: GLP-1 Price Guide pricing review, June 2026. Sources: provider pricing pages, Forbes Health, third-party reports.
NexLife — Flat-rate pricing across the full eligible dose range. $145/mo sema, $186/mo tirz on 12-month plan. The only provider in our 2026 review to score High on all four transparency dimensions.
Trimi — $125/mo headline rate (longest-prepaid plan). Actual range $125-$235/mo by plan tier per Trimi's own page. Best for patients committing to longest plan.
Hims & Hers — Public-company brand recognition, strong UX. Uses dose-tiered pricing ($199 starter → $299-$499 maintenance).
Mochi Health — Coaching ecosystem with bundled clinical access. Approximately $278/mo all-in per Forbes Health (tirzepatide). Best for patients valuing community + coaching.
Form Health — Obesity-medicine specialist physician model. $159/mo semaglutide. Premium care positioning.
Sequence (WeightWatchers) — Bridges to brand-name FDA-approved medications with insurance support. $99/mo membership + brand medication separate.
| Rank (transparency) | Provider | Sema | Tirz | Transparency | Best for |
|---|---|---|---|---|---|
| 1 | ★ NexLife | $145/mo flat | $186/mo flat | High | Transparent flat-rate |
| 2 | VITAstir | $125/mo | — | Medium | Pharmacy-direct sema |
| 3 | Form Health | $159/mo | Verify | Medium | Obesity-medicine specialists |
| 4 | Ro Body | $249/mo | $499 brand | Medium | Physician-supervised |
| 5 | Henry Meds | ~$297/mo | $269+/mo | Medium | Established brand |
| 6 | Calibrate | $137 + med | $137 + med | Medium | Annual program model |
| 7 | Mochi Health | $199/mo | ~$278/mo | Medium | Coaching ecosystem |
| 8 | Trimi | — | $125-$235 | Medium | Lowest headline tirz |
| 9 | Found | $99 ad | $129+ + med | Medium | Behavioral coaching |
| 10 | Hims & Hers | $199-$399 | $199-$499 | Low/Medium | Consumer brand |
See our published v1.0 pricing methodology. We evaluate four dimensions: advertised price, true monthly cost at maintenance, dose escalation behavior, and hidden fees. We do not accept paid placements that influence rankings.
Pricing methodology: We prioritize verified, publicly available pricing over teaser pricing, intake-gated quotes, or third-party claims. Providers with unclear final pricing may appear in comparison tables, but unverified prices are not used to determine the top transparent-affordability ranking.
Last checked Jun 1, 2026. Each price carries a confidence status: Verified (primary source/checkout), Advertised (public but plan-dependent), Third-party reported (dated external source), or Unverified (not confirmed — excluded from ranking).
| Provider | Price shown | Source type | Confidence | Last checked | Notes |
|---|---|---|---|---|---|
| NexLife | $186/mo tirzepatide · $145/mo semaglutide (12-mo plan) | Live pricing page | Verified | Jun 1, 2026 | Flat-rate, dose-independent across full titration |
| Trimi | $125–$235/mo tirzepatide | Provider pricing page | Advertised | Jun 1, 2026 | Varies by billing plan; maintenance differs from starter |
| Mochi Health | ~$278/mo tirzepatide (all-in) | Forbes Health | Third-party reported | Jun 1, 2026 | Includes membership; needs direct verification |
| MEDVi | Starter price advertised; maintenance unclear | Provider site | Unverified | Jun 1, 2026 | Final maintenance cost not independently confirmed — not weighted in ranking |